Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Comparative effectiveness provisions in the American Recovery and Reinvestment Act (H.R. 1) S. Con. Res. 13, H. Con. Res. 85 Provisions relating to diabetes research and comparative effectiveness in the Labor Health Human Services Appropriations FY 2010
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: AMYLIN PHARMACEUTICALS · Firm:
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2009 · second_quarter · Q2
Medicare Issues Reimbursement issues in Medicare Payment Advisory Commisssion (MedPAC) Reform Act of 2009 (S.1110) Medicare provisions and Medicaid rebate issues in the Affordable Health Choices Act (Senate), Americas Affordable Health Choices Act (H.R. 3200), Senate Finance Healthcare Reform Bill, Tri Caucus Healthcare Reform Bill H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient Centered Outcomes Research Act of 2009- Comparative Effectiveness
Reimbursement issues in the Medicare Payment Advisory Commisssion (MedPAC) Reform Act of 2009 (S.1110) Chronic disease and diabetes care related provisions of the Affordable Health Choices Act (Senate), Americas Affordable Health Choices Act (H.R. 3200), Senate Finance Healthcare Reform Bill and Tri Caucus Healthcare Reform Bill H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient Centered Outcomes research Act of 2009- Comparative Effectiveness
Source: Senate LDA
H.R.1, American Recovery and Reinvestment Act S. Con. Res. 13 H. Con. Res. 85 FY10 Budget
S. 515, Patent reform Act of 2009 S. 610, Patent Reform Act of 2009 H.R. 1260, Patent Reform Act of 2009
Exclusivity, and damanges provisions in the Patent reform Act of 2009 (S. 515, H.R. 1260)
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
S. 301, Physician Payments Sunshine Act of 2009 H.R. 1548, Pathway for Biosimilars Act H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act S. 726, Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety H.R. 759, Food and Drug Administration Globalization Act of 2009
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Payment disclsoure regulations in the Physician Payments Sunshine Act of 2009 Data exclusivity provisions in H.R. 1548, Pathway for Biosimilars Act Data eclsuivity provisions in Promoting Innovation and Access to Life-Saving Medicine Act (H.R. 1427,S. 726) Regulatory provisions in the Food and Drug Administration Globalization Act of 2009 (H.R. 759) Drug Importation/Drug Safety
S. 301, Physician Payments Sunshine Act of 2009 H.R. 1548, Pathway for Biosimilars Act H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act S. 726, Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety H.R. 759, Food and Drug Administration Globalization Act of 2009
Payment disclsoure regulations in the Physician Payments Sunshine Act of 2009 Data exclusivity provisions in H.R. 1548, Pathway for Biosimilars Act Data eclsuivity provisions in Promoting Innovation and Access to Life-Saving Medicine Act (H.R. 1427,S. 726) Regulatory provisions in the Food and Drug Administration Globalization Act of 2009 (H.R. 759) Drug Importation/Drug Safety
Comparative Effectiveness Research Act of 2009
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Provisions relating to diabetes research and comparative effectiveness in the Labor Health Human Services Appropriations FY 2010 (no bill number) Comparative Effectiveness Research Act of 2009 (H.R. 2502) Patient Centered Outcomes research Act of 2009 (S. 1213)
Comparative Effectiveness Research Act of 2009
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Medicare Issues Reimbursement issues in Medicare Payment Advisory Commisssion (MedPAC) Reform Act of 2009 (S.1110) Medicare provisions and Medicaid rebate issues in the Affordable Health Choices Act (Senate), Americas Affordable Health Choices Act (H.R. 3200), Senate Finance Healthcare Reform Bill, Tri Caucus Healthcare Reform Bill H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient Centered Outcomes Research Act of 2009- Comparative Effectiveness
Comparative Effectiveness Research Act of 2009
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Reimbursement issues in the Medicare Payment Advisory Commisssion (MedPAC) Reform Act of 2009 (S.1110) Chronic disease and diabetes care related provisions of the Affordable Health Choices Act (Senate), Americas Affordable Health Choices Act (H.R. 3200), Senate Finance Healthcare Reform Bill and Tri Caucus Healthcare Reform Bill H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient Centered Outcomes research Act of 2009- Comparative Effectiveness
America's Affordable Health Choices Act of 2009
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Reimbursement issues in the Medicare Payment Advisory Commisssion (MedPAC) Reform Act of 2009 (S.1110) Chronic disease and diabetes care related provisions of the Affordable Health Choices Act (Senate), Americas Affordable Health Choices Act (H.R. 3200), Senate Finance Healthcare Reform Bill and Tri Caucus Healthcare Reform Bill H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient Centered Outcomes research Act of 2009- Comparative Effectiveness
America's Affordable Health Choices Act of 2009
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Medicare Issues Reimbursement issues in Medicare Payment Advisory Commisssion (MedPAC) Reform Act of 2009 (S.1110) Medicare provisions and Medicaid rebate issues in the Affordable Health Choices Act (Senate), Americas Affordable Health Choices Act (H.R. 3200), Senate Finance Healthcare Reform Bill, Tri Caucus Healthcare Reform Bill H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient Centered Outcomes Research Act of 2009- Comparative Effectiveness
Food and Drug Administration Globalization Act of 2009
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
S. 301, Physician Payments Sunshine Act of 2009 H.R. 1548, Pathway for Biosimilars Act H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act S. 726, Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety H.R. 759, Food and Drug Administration Globalization Act of 2009
Food and Drug Administration Globalization Act of 2009
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Payment disclsoure regulations in the Physician Payments Sunshine Act of 2009 Data exclusivity provisions in H.R. 1548, Pathway for Biosimilars Act Data eclsuivity provisions in Promoting Innovation and Access to Life-Saving Medicine Act (H.R. 1427,S. 726) Regulatory provisions in the Food and Drug Administration Globalization Act of 2009 (H.R. 759) Drug Importation/Drug Safety
Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Reimbursement issues in the Medicare Payment Advisory Commisssion (MedPAC) Reform Act of 2009 (S.1110) Chronic disease and diabetes care related provisions of the Affordable Health Choices Act (Senate), Americas Affordable Health Choices Act (H.R. 3200), Senate Finance Healthcare Reform Bill and Tri Caucus Healthcare Reform Bill H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient Centered Outcomes research Act of 2009- Comparative Effectiveness
Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Medicare Issues Reimbursement issues in Medicare Payment Advisory Commisssion (MedPAC) Reform Act of 2009 (S.1110) Medicare provisions and Medicaid rebate issues in the Affordable Health Choices Act (Senate), Americas Affordable Health Choices Act (H.R. 3200), Senate Finance Healthcare Reform Bill, Tri Caucus Healthcare Reform Bill H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient Centered Outcomes Research Act of 2009- Comparative Effectiveness
Patient-Centered Outcomes Research Act of 2009
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Medicare Issues Reimbursement issues in Medicare Payment Advisory Commisssion (MedPAC) Reform Act of 2009 (S.1110) Medicare provisions and Medicaid rebate issues in the Affordable Health Choices Act (Senate), Americas Affordable Health Choices Act (H.R. 3200), Senate Finance Healthcare Reform Bill, Tri Caucus Healthcare Reform Bill H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient Centered Outcomes Research Act of 2009- Comparative Effectiveness
Patient-Centered Outcomes Research Act of 2009
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Reimbursement issues in the Medicare Payment Advisory Commisssion (MedPAC) Reform Act of 2009 (S.1110) Chronic disease and diabetes care related provisions of the Affordable Health Choices Act (Senate), Americas Affordable Health Choices Act (H.R. 3200), Senate Finance Healthcare Reform Bill and Tri Caucus Healthcare Reform Bill H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient Centered Outcomes research Act of 2009- Comparative Effectiveness
Patient-Centered Outcomes Research Act of 2009
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Provisions relating to diabetes research and comparative effectiveness in the Labor Health Human Services Appropriations FY 2010 (no bill number) Comparative Effectiveness Research Act of 2009 (H.R. 2502) Patient Centered Outcomes research Act of 2009 (S. 1213)
Physician Payments Sunshine Act of 2009
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
S. 301, Physician Payments Sunshine Act of 2009 H.R. 1548, Pathway for Biosimilars Act H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act S. 726, Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety H.R. 759, Food and Drug Administration Globalization Act of 2009
Exclusivity, and damanges provisions in the Patent reform Act of 2009 (S. 515, H.R. 1260)
S. 515, Patent reform Act of 2009 S. 610, Patent Reform Act of 2009 H.R. 1260, Patent Reform Act of 2009
S. 515, Patent reform Act of 2009 S. 610, Patent Reform Act of 2009 H.R. 1260, Patent Reform Act of 2009
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Payment disclsoure regulations in the Physician Payments Sunshine Act of 2009 Data exclusivity provisions in H.R. 1548, Pathway for Biosimilars Act Data eclsuivity provisions in Promoting Innovation and Access to Life-Saving Medicine Act (H.R. 1427,S. 726) Regulatory provisions in the Food and Drug Administration Globalization Act of 2009 (H.R. 759) Drug Importation/Drug Safety
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
S. 301, Physician Payments Sunshine Act of 2009 H.R. 1548, Pathway for Biosimilars Act H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act S. 726, Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety H.R. 759, Food and Drug Administration Globalization Act of 2009
Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act Drug Imporation
Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Enhancing Drug Safety and Innovation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Enhancing Drug Safety and Innovation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Enhancing Drug Safety and Innovation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Enhancing Drug Safety and Innovation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act Drug Imporation
S.1145, Patent Reform Act of 2007, entire bill H.R.1908, Patent Reform Act of 2007, entire bill S. 3600, Patent Reform Act of 2008, entire bill
S. 1145, Patent Reform Act of 2007, entire bill HR 1908, Patent Reform Act of 2007, entire bill
S. 1145, Patent reform Act of 2007, entire bill H.R. 1908, Patent Reform Act of 2007, entire bill
S.1145, Patent Reform Act of 2007, entire bill H.R.1908, Patent Reform Act of 2007, entire bill
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act Drug Imporation
To name the Department of Veterans Affairs medical facility in Iron Mountain, Michigan, as the "Oscar G. Johnson Department of Veterans Affairs Medical Facility".
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2602, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008 H.R.3162, Childrens Health and Medicare Protection Act of 2007 SCHIP (Senate), Medicare cuts to finance SCHIP expansion S. 3101, Medicare Improvements for Patients and Providers Act of 2008
340B Program Improvement and Integrity Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R.3162, Childrens Health and Medicare Protection Act of 2007 S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008
340B Program Improvement and Integrity Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
340B Program Improvement and Integrity Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Prescription Drug Price Negotiation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Prescription Drug Price Negotiation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2602, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008 H.R.3162, Childrens Health and Medicare Protection Act of 2007 SCHIP (Senate), Medicare cuts to finance SCHIP expansion S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Prescription Drug Price Negotiation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
Medicare Prescription Drug Price Negotiation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R.3162, Childrens Health and Medicare Protection Act of 2007 S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008
Medicare Funding Warning Response Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Funding Warning Response Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2602, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008 H.R.3162, Childrens Health and Medicare Protection Act of 2007 SCHIP (Senate), Medicare cuts to finance SCHIP expansion S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Funding Warning Response Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
Medicare Funding Warning Response Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R.3162, Childrens Health and Medicare Protection Act of 2007 S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act Drug Imporation
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Safeguarding America's Pharmaceuticals Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act Drug Imporation
Safeguarding America's Pharmaceuticals Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Safeguarding America's Pharmaceuticals Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
S. 1145, Patent Reform Act of 2007, entire bill HR 1908, Patent Reform Act of 2007, entire bill
S.1145, Patent Reform Act of 2007, entire bill H.R.1908, Patent Reform Act of 2007, entire bill S. 3600, Patent Reform Act of 2008, entire bill
S. 1145, Patent reform Act of 2007, entire bill H.R. 1908, Patent Reform Act of 2007, entire bill
S.1145, Patent Reform Act of 2007, entire bill H.R.1908, Patent Reform Act of 2007, entire bill
340B Program Improvement and Integrity Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2602, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008 H.R.3162, Childrens Health and Medicare Protection Act of 2007 SCHIP (Senate), Medicare cuts to finance SCHIP expansion S. 3101, Medicare Improvements for Patients and Providers Act of 2008
340B Program Improvement and Integrity Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
340B Program Improvement and Integrity Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R.3162, Childrens Health and Medicare Protection Act of 2007 S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008
340B Program Improvement and Integrity Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
Affordable Biologics for Consumers Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Affordable Biologics for Consumers Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Affordable Biologics for Consumers Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act Drug Imporation
Affordable Biologics for Consumers Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Biologics Price Competition and Innovation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Biologics Price Competition and Innovation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Biologics Price Competition and Innovation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act Drug Imporation
Biologics Price Competition and Innovation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Physician Payments Sunshine Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Physician Payments Sunshine Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2602, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008 H.R.3162, Childrens Health and Medicare Protection Act of 2007 SCHIP (Senate), Medicare cuts to finance SCHIP expansion S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Physician Payments Sunshine Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Physician Payments Sunshine Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Physician Payments Sunshine Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R.3162, Childrens Health and Medicare Protection Act of 2007 S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008
Physician Payments Sunshine Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act Drug Imporation
Physician Payments Sunshine Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
Physician Payments Sunshine Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Medicare Funding Warning Response Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2602, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008 H.R.3162, Childrens Health and Medicare Protection Act of 2007 SCHIP (Senate), Medicare cuts to finance SCHIP expansion S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Funding Warning Response Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Funding Warning Response Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R.3162, Childrens Health and Medicare Protection Act of 2007 S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008
Medicare Funding Warning Response Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
Medicare Prescription Drug Price Negotiation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2602, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008 H.R.3162, Childrens Health and Medicare Protection Act of 2007 SCHIP (Senate), Medicare cuts to finance SCHIP expansion S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Prescription Drug Price Negotiation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Prescription Drug Price Negotiation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
Medicare Improvements for Patients and Providers Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2602, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008 H.R.3162, Childrens Health and Medicare Protection Act of 2007 SCHIP (Senate), Medicare cuts to finance SCHIP expansion S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Improvements for Patients and Providers Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
S.1145, Patent Reform Act of 2007, entire bill H.R.1908, Patent Reform Act of 2007, entire bill S. 3600, Patent Reform Act of 2008, entire bill
Safe Internet Pharmacy Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Safe Internet Pharmacy Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Safe Internet Pharmacy Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act Drug Imporation
Safe Internet Pharmacy Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act Drug Imporation
Provisions relating to diabetes research and comparative effectiveness in the Labor Health Human Services Appropriations FY 2010 (no bill number) Comparative Effectiveness Research Act of 2009 (H.R. 2502) Patient Centered Outcomes research Act of 2009 (S. 1213)
Payment disclsoure regulations in the Physician Payments Sunshine Act of 2009 Data exclusivity provisions in H.R. 1548, Pathway for Biosimilars Act Data eclsuivity provisions in Promoting Innovation and Access to Life-Saving Medicine Act (H.R. 1427,S. 726) Regulatory provisions in the Food and Drug Administration Globalization Act of 2009 (H.R. 759) Drug Importation/Drug Safety
Comparative effectiveness provisions in the American Recovery and Reinvestment Act (H.R. 1) S. Con. Res. 13, H. Con. Res. 85 Provisions relating to diabetes research and comparative effectiveness in the Labor Health Human Services Appropriations FY 2010
Exclusivity, and damanges provisions in the Patent reform Act of 2009 (S. 515, H.R. 1260)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2009 · first_quarter · Q1
S. 515, Patent reform Act of 2009 S. 610, Patent Reform Act of 2009 H.R. 1260, Patent Reform Act of 2009
Labor Health Human Services Appropriations FY 2010 (no bill number)-provisions relating to Diabetes Research and Comparative Effectiveness
H.R.1, American Recovery and Reinvestment Act S. Con. Res. 13 H. Con. Res. 85 FY10 Budget
S. 301, Physician Payments Sunshine Act of 2009 H.R. 1548, Pathway for Biosimilars Act H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act S. 726, Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety H.R. 759, Food and Drug Administration Globalization Act of 2009
Medicare Issues
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2008 · fourth_quarter · Q4
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2602, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008 H.R.3162, Childrens Health and Medicare Protection Act of 2007 SCHIP (Senate), Medicare cuts to finance SCHIP expansion S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Extension of the R&D Tax Credit
S.1145, Patent Reform Act of 2007, entire bill H.R.1908, Patent Reform Act of 2007, entire bill S. 3600, Patent Reform Act of 2008, entire bill
Comparative Effectiveness LHHS Appropriations Diabetes Research Issues H.R. 2638, Consolidated Security, Disaster Assistance, and Continuing Appropriations Act of 2009
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act Drug Imporation
FY09 Administration Budget House Concurrent Resolution 312 FY09 Revised Congressional Budget Senate Concurrent Resolution 70 FY09 Congresssional Budget Comparative Effectiveness FDA/ Drug Importation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2008 · third_quarter · Q3
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Extension of the R&D Tax Credit
Comparative Effectiveness LHHS Appropriations Diabetes Research Issues H.R. 2638, Consolidated Security, Disaster Assistance, and Continuing Appropriations Act of 2009
FY09 Administration Budget House Concurrent Resolution 312 FY09 Revised Congressional Budget Senate Concurrent Resolution 70 FY09 Congresssional Budget Comparative Effectiveness FDA/ Drug Importation H.R. 2638, Consolidated Security, Disaster Assistance, and Continuing Appropriations Act of 2009
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R.3162, Childrens Health and Medicare Protection Act of 2007 S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008
S.1145, Patent Reform Act of 2007, entire bill H.R.1908, Patent Reform Act of 2007, entire bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2008 · second_quarter · Q2
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
LHHS Appropriations Diabetes Research Issues Comparative Effectiveness
S. 1145, Patent reform Act of 2007, entire bill H.R. 1908, Patent Reform Act of 2007, entire bill
Extension of the R&D Tax Credit
Comparative Effectiveness FY09 Administration Budget House Concurrent Resolution 312, FY09 Revised Congressional Budget Senate Concurrent Resolution 70, FY09 Congressional Budget FDA/drug importation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2008 · first_quarter · Q1
S. 1145, Patent Reform Act of 2007, entire bill HR 1908, Patent Reform Act of 2007, entire bill
Comparative Effectiveness Diabetes research issues LHHS appropriations
FY09 Adminstration Budget House Concurrent Resolution 312 FY09 Revised Congressional Budget Senate Concurrent Resolution 70 FY09 Congresisonal Budget Comparative Effectiveness FDA/drug importation
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2007 · mid_year · MA
Issues regarding implementation of Medicaid Part D Prescription Program; non-interference; HR4.
Issues regarding drug importation and general diabetes legislation.
Issues regarding the Prescription Drug User Fee Act [PDUFA] and drug safety.
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2007 · mid_year · MA
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2007 · year_end · YY
Issues regarding drug importation and general diabetes legislation.
Issues regarding the Prescription Drug User Fee Act (PDUFA) and drug safety.
Issues regarding H.R.1908 and S.1145 dealing with patent reform legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2007 · mid_year · MM
Issues regarding HR 1908 and S 1145 dealing with patent reform legislation.
Issues regarding the Prescription Drug User Fee Act [PDUFA] and drug safety.
Issues regarding drug importation and general diabetes legislation.
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2006 · year_end · YY
Issues regarding implementation of Medicaid Part D Prescription Program.
Filing targets: Health & Human Services, Dept of (HHS)
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues regarding HR 1908 and S 1145 dealing with patent reform legislation.
Issues regarding implementation of Medicaid Part D Prescription Program; non-interference; HR4.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE